Peptris is an AI-powered preclinical drug discovery company that leverages advanced AI/ML to design novel drug candidates and accelerate the drug discovery and development cascade. The company operates virtually, outsourcing wet lab work to CROs and biotech partners, with partnerships spanning academia, biotech, and pharma, including rare disease organizations. Based in India, Peptris focuses on generating novel chemical entities, repurposing approved drugs, and rescuing clinical candidates through an automated platform that integrates unsupervised learning and generative AI to streamline research from discovery to preclinical validation.
No recent news for this company.